Krzysztof Bujko, MD, on Rectal Cancer: Results of a Phase III Trial

2016 Gastrointestinal Cancers Symposium
Tweet this page

Krzysztof Bujko, MD, of the Maria Skłodowska Curie Memorial Cancer Centre, discusses the results of a multicenter Polish study on neoadjuvant chemoradiation for fixed cT3 or cT4 rectal cancer (Abstract 489).

Advertisement

Advertisement



Advertisement